Lexeo Therapeutics (LXEO) Non-Current Assets (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Non-Current Assets of $36.99 million for Q2 2026, up 2.7% from $36.01 million a year earlier but down 25.3% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Lexeo Therapeutics' Non-Current Assets came in at $80.3 million, up 285.6% from FY2024.
- Annual Non-Current Assets shows a three-year compound annual growth rate of 67.7% (FY2022 to FY2025).
- In prior years, Lexeo Therapeutics' Non-Current Assets was $20.82 million in FY2024 (+34.2%), $15.51 million in FY2023 (-8.9%) and $17.03 million in FY2022.
- Quarterly Non-Current Assets has run from a low of $14.41 million in Q3 2024 to a high of $80.3 million in Q4 2025 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last seven quarters, with growth averaging 80.6% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2025, with growth of 285.6%; the weakest was Q3 2024, with a decline of 9.1%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $49.49 million (Q1 2026), $80.3 million (Q4 2025) and $16.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Lexeo Therapeutics | 246.87 Mn | 246.87 Mn | - | 36.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.99 Mn |
| Mar 31, 2026 | 49.49 Mn |
| Dec 31, 2025 | 80.30 Mn |
| Sep 30, 2025 | 16.05 Mn |
| Jun 30, 2025 | 36.01 Mn |
| Mar 31, 2025 | 20.42 Mn |
| Dec 31, 2024 | 20.82 Mn |
| Sep 30, 2024 | 14.41 Mn |
| Jun 30, 2024 | 14.86 Mn |
| Mar 31, 2024 | 15.12 Mn |
| Dec 31, 2023 | 15.51 Mn |
| Sep 30, 2023 | 15.85 Mn |
| Dec 31, 2022 | 17.03 Mn |
API Access
Lexeo Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();